BioInvent International AB (BINV) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.082x

Based on the latest financial reports, BioInvent International AB (BINV) has a cash flow conversion efficiency ratio of 0.082x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr66.78 Million ≈ $7.19 Million USD) by net assets (Skr810.74 Million ≈ $87.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BINV equity to assets ratio to measure how much of total assets are equity-financed.

BioInvent International AB - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how BioInvent International AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BioInvent International AB earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

BioInvent International AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BioInvent International AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kafrit TA:KAFR	0.104x
AN2 Therapeutics Inc NASDAQ:ANTX	-0.099x
Media Capital LS:MCP	-0.013x
E-Life Mall Corp TW:6281	0.110x
Liberty Global PLC Class B NASDAQ:LBTYB	0.023x
Clavister Holding AB (publ.) ST:CLAV	-0.204x
Satellos Bioscience Inc. Common Stock NASDAQ:MSLE	-0.261x
Universal Microelectronics Co Ltd TW:2413	0.066x

Annual Cash Flow Conversion Efficiency for BioInvent International AB (2002–2024)

The table below shows the annual cash flow conversion efficiency of BioInvent International AB from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see BINV market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr885.82 Million ≈ $95.33 Million	Skr-380.47 Million ≈ $-40.94 Million	-0.430x	-64.64%
2023-12-31	Skr1.31 Billion ≈ $140.95 Million	Skr-341.69 Million ≈ $-36.77 Million	-0.261x	-916.36%
2022-12-31	Skr1.61 Billion ≈ $172.84 Million	Skr-41.23 Million ≈ $-4.44 Million	-0.026x	+85.73%
2021-12-31	Skr1.37 Billion ≈ $147.11 Million	Skr-245.84 Million ≈ $-26.46 Million	-0.180x	-113.52%
2020-12-31	Skr743.50 Million ≈ $80.01 Million	Skr-62.62 Million ≈ $-6.74 Million	-0.084x	+88.62%
2019-12-31	Skr169.44 Million ≈ $18.23 Million	Skr-125.43 Million ≈ $-13.50 Million	-0.740x	+54.13%
2018-12-31	Skr87.62 Million ≈ $9.43 Million	Skr-141.39 Million ≈ $-15.22 Million	-1.614x	-176.96%
2017-12-31	Skr130.22 Million ≈ $14.01 Million	Skr-75.88 Million ≈ $-8.17 Million	-0.583x	-86.35%
2016-12-31	Skr230.44 Million ≈ $24.80 Million	Skr-72.05 Million ≈ $-7.75 Million	-0.313x	+87.31%
2015-12-31	Skr29.45 Million ≈ $3.17 Million	Skr-72.57 Million ≈ $-7.81 Million	-2.464x	-69.91%
2014-12-31	Skr52.43 Million ≈ $5.64 Million	Skr-76.03 Million ≈ $-8.18 Million	-1.450x	-30.04%
2013-12-31	Skr49.01 Million ≈ $5.27 Million	Skr-54.65 Million ≈ $-5.88 Million	-1.115x	+68.83%
2012-12-31	Skr47.62 Million ≈ $5.13 Million	Skr-170.38 Million ≈ $-18.34 Million	-3.578x	-790.00%
2011-12-31	Skr137.95 Million ≈ $14.85 Million	Skr-55.45 Million ≈ $-5.97 Million	-0.402x	+74.66%
2010-12-31	Skr74.19 Million ≈ $7.98 Million	Skr-117.70 Million ≈ $-12.67 Million	-1.586x	+30.58%
2009-12-31	Skr55.63 Million ≈ $5.99 Million	Skr-127.14 Million ≈ $-13.68 Million	-2.285x	-1308.90%
2008-12-31	Skr231.30 Million ≈ $24.89 Million	Skr43.73 Million ≈ $4.71 Million	0.189x	+220.57%
2007-12-31	Skr214.12 Million ≈ $23.04 Million	Skr12.63 Million ≈ $1.36 Million	0.059x	+106.42%
2006-12-31	Skr110.15 Million ≈ $11.85 Million	Skr-101.23 Million ≈ $-10.89 Million	-0.919x	-90.80%
2005-12-31	Skr219.00 Million ≈ $23.57 Million	Skr-105.48 Million ≈ $-11.35 Million	-0.482x	-15.43%
2004-12-31	Skr212.68 Million ≈ $22.89 Million	Skr-88.74 Million ≈ $-9.55 Million	-0.417x	-92.09%
2003-12-31	Skr304.96 Million ≈ $32.82 Million	Skr-66.25 Million ≈ $-7.13 Million	-0.217x	-710.31%
2002-12-31	Skr394.25 Million ≈ $42.43 Million	Skr-10.57 Million ≈ $-1.14 Million	-0.027x	--

About BioInvent International AB

ST:BINV Sweden Biotechnology

Market Cap

$160.40 Million

Skr1.49 Billion SEK

Market Cap Rank

#17348 Global

#294 in Sweden

Share Price

Skr22.65

Change (1 day)

+0.67%

52-Week Range

Skr21.25 - Skr41.05

All Time High

Skr95.26